Doctor Jack's Stock Medicine
Collapse
X
-
Mrvl
Originally posted by Jack Haddad View PostI bought 8 blocks at 20.11 to 20.13, and wrote 800 Dec Calls for 1.05/contract. The prospects of MRVL keeps improving. Until I see otherwise, I won’t stop accumulating or trading the stock.
Comment
-
-
Mrvl
Jack
Is this statement about a drag on future earnings for several qtrs going to provide some instability in near term qtrly earnings ??
from this ams report.
Marvell's overall financial performance—and the company has been one of the best performers in the semiconductor sector—could suffer for several quarters to come. Marvell expects the acquired business to break even by the end of 2007. Charlie Glavin, an analyst with Needham & Co., says it's more likely to take 18 months
Comment
-
-
Originally posted by grebnet View PostJack
Is this statement about a drag on future earnings for several qtrs going to provide some instability in near term qtrly earnings ??
from this ams report.
Marvell's overall financial performance—and the company has been one of the best performers in the semiconductor sector—could suffer for several quarters to come. Marvell expects the acquired business to break even by the end of 2007. Charlie Glavin, an analyst with Needham & Co., says it's more likely to take 18 months
Comment
-
-
Intc
In a note sent to clients, HSBC analyst Rohit Pandey stated that he has changed his bearish outlook on INTC, citing several facotrs: 1. An edge over competitor Advanced Micro Devices Inc. 2. The ability of INTC to deliver earnings growth despite inventory concerns. “We believe that Intel has a better handle than Advanced Micro Devices on the cost side of the equation — both on the product and operating costs. On the revenue side of the equation, we believe that pricing and product superiority remain key drivers,” Pandey wrote.
In an interview with INTC CFO Andy Bryant, UBS analyst Alex Gauna realized that Intel’s margins hit a cyclical bottom in the third quarter. “Operating margin should expand in 2007 as 45 nanometer process technology leadership and the benefits of Intel’s restructuring enables lower costs,” Gauna said in a note to investors
Comment
-
-
Intc/imcl/mrvl
Jack,
IMCL is trading at about $29.75. The DEC $30 call has a premium of $.90. Is this something you'd be interested in, or do you see more downside for IMCL? Yes, I know the call isn't deep in the money, as per your usual style of trading.
INTC: are you a buyer of INTC at this time?
MRVL:still hot on this one?
Comment
-
-
Originally posted by New-born baby View PostJack,
IMCL is trading at about $29.75. The DEC $30 call has a premium of $.90. Is this something you'd be interested in, or do you see more downside for IMCL? Yes, I know the call isn't deep in the money, as per your usual style of trading.
INTC: are you a buyer of INTC at this time?
MRVL:still hot on this one?
Comment
-
-
Originally posted by Jack Haddad View PostI'm very excited about Ichan taking over the IMCL's board as chairman.
Looking forward to trial results in NSCLC, pancreatic, earlier-stage CRC, and angiogenesis inhibitors.—Rob
Comment
-
-
Comment